Cbfa1 in bone development

Current Opinion in Genetics and Development

Volumn 8, Issue 4, 1998, Pages 494-499

  Komori, Toshihisa ^a   Kishimoto, Tadamitsu ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CORE BINDING FACTOR ALPHA 1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

BONE DEVELOPMENT; CELL DIFFERENTIATION; CLEIDOCRANIAL DYSPLASIA; EMBRYO; GENE LOCUS; GENE MUTATION; GENE TARGETING; MOUSE; MULTIGENE FAMILY; NONHUMAN; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

EID: 0031718042     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(98)80123-8     Document Type: Article

References (50)

1. Marks SC, Hermey DC: The structure and development of bone. In Principles of Bone Biology. Edited by Bilezikian JP, Raisz LG, Rodan GA. London: Academic Press; 1996:3-14.
2. Suda T, Udagawa N, Takahashi N: Cells of bone: osteoclast generation. In Principles of Bone Biology. Edited by Bilezikian JP, Raisz LG, Rodan GA. London: Academic Press; 1996:87-102.
3. Aubin JE, Turksen K, Heersche JNM: Osteoblastic lineage. In Cellular and Molecular Biology of Bone. Edited by Noda M. London: Academic Press; 1993:1-45.
4. Weintraub H: The MyoD family and myogenesis: redundancy, networks, and thresholds. Cell 1993, 75:1241-1244.
5. Tontonoz P, Hu E, Spiegelman BM: Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell 1994, 79:1147-1156.
6. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M et al.: Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997, 89:755-764. Cbfa1-deficient mice completely lack bone formation and the maturation of osteoblasts and osteoclasts is blocked. Cbfa1 is preferentially expressed in osteoblasts and the markers of osteoblast differentiation are barely detectable in Cbfa1-deficient mice. These findings clearly indicate that Cbfa1 is an essential transcription factor for bone formation, especially osteoblast differentiation.
7. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GWH, Beddington RSP, Mundlos S, Olsen BR et al.: Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 1997, 89:765-771. This study also shows the lack of bone formation in mice homozygously mutated in the Cbfa1 locus and presents in detail the abnormalities found in these heterozygously mutated mice. These abnormalities are similar to those of CCD. Cbfa1 was deleted in radiation-induced Ccd mutant mice. Cbfa1 expression in embryogenesis was examined using reporter β-galactosidase inserted in the Cbfa1 locus and Cbfa1 expression in the early stage (d10.5) was examined.
8. 3 suppresses Cbfa1 expression in primary osteoblasts. Transfection of the Cbfa1 expression vector induces osteoblastic markers, and antisense oligonucleotide suppresses type I collagen expression in vitro. These data suggest that Cbfa1 is a specific transcription factor for osteoblast differentiation.
9. Ogawa E, Maruyama M, Kagoshima H, Inuzuka M, Lu J, Satake M, Shigesada K, Ito Y: PEBP2/PEA2 represents a new family of transcription factor homologous to the products of the Drosophila runt and the human AML1 gene. Proc Natl Acad Sci USA 1993, 90:6859-6863.
10. Bae SC, Yamaguchi-Iwai Y, Ogawa E, Maruyama M, Inuzuka M, Kagoshima H, Shigesada K, Satake M, Ito Y: Isolation of PEBP2αB cDNA representing the mouse homolog of human acute myeloid leukemia gene, AML1. Oncogene 1993, 8:809-814.
11. Bae SC, Takahashi E, Zhang YW, Ogawa E, Shigesada K, Namba Y, Satake M, Ito Y: Cloning, mapping and expression of PEBP2αC, a third gene encoding the mammalian Runt domain. Gene 1995, 159:245-248.
12. Kania MA, Bonner AS, Duffy JB, Gergen JP: The Drosophila segmentation gene runt encodes a novel nuclear regulatory protein that is also expressed in the developing nervous system. Genes Dev 1990, 4:1701-1713.
13. Ogawa E, Inuzaka M, Maruyama M, Satake M, Naito-Fujimoto M, Ito Y, Shigesada K: Molecular cloning and characterization of PEBP2β, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2α. Virology 1993, 194:314-331.
14. Wang S, Wang Q, Crute BE, Melnikova IN, Keller SR, Speck NA: Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor. Mol Cell Biol 1993, 13:3324-3339.
15. Zeng C, Wijnen AJV, Stein JL, Meyers S, Sun W, Shopland L, Lawrence JB, Penman S, Lian JB, Stein GS, Hiebert SW: Identification of a nuclear matrix targeting signal in the leukemia and bone-related AML/CBF-α transcription factors. Proc Natl Acad Sci USA 1997, 94:6746-6751. Nuclear matrix targeting signal is identified in the carboxyl terminus of AML-1 (Cbfa2). A similar sequence is also present in Cbfa1 and Cbfa3. The importance of the interaction between the transcription factor and nuclear matrix is addressed.
16. Kamachi Y, Ogawa E, Asano M, Ishida S, Murakami Y, Satake M, Ito Y, Shigesada K: Purification of a mouse nuclear factor that binds to both the A and B cores of the polyomavirus enhancer. J Virol 1990, 64:4808-4819.
17. Wang S, Speck NA: Purification of core-binding factor, a protein that binds the conserved core site in murine leukemia virus enhancers. Mol Cell Biol 1992, 12:89-102.
18. Okuda T, van Deursen J, Hiebert SW, Grosveld G, Downing JR: AML1, the target of multiple chromosomal translocation in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 1996, 84:321-330.
19. Wang Q, Stancy T, Binder M, Marin-Padilla M, Sharpe AH, Speck NA: Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc Natl Acad Sci USA 1996, 93:3444-3449.
20. Sasaki K, Yagi H, Bronson RT, Tominaga K, Matsunashi T, Deguchi K, Tani Y, Kishimoto T, Komori T: Absence of fetal liver hematopoiesis in mice deficient in transcriptional coactivator core binding factor β. Proc Natl Acad Sci USA 1996, 93:12359-12363.
21. Wang Q, Stacy T, Miller JD, Lewis AF, Gu TL, Huang X, Bushweller JH, Bories JC, Alt FW, Ryan G et al.: The CBFb subunit is essential for CBFa2 (AML1) function in vivo. Cell 1996, 87:697-708.
22. Satake M, Nomura S, Yamaguchi-Iwai Y, Takahama Y, Hashimoto Y, Niki M, Kitamura Y, Ito Y: Expression of the runt domain-encoding PEBP2α genes in T cells during thymic development. Mol Cell Biol 1995, 15:1662-1670.
23. •]. Several other isoforms of Cbfa1 are also identified. The oncogenic involvement of Cbfa1 and its cooperation with myc in oncogenesis is indicated.
24. Geoffroy V, Corral DA, Zhou L, Lee B, Karsenty G: Genomic organization, expression of the human CBFA1 gene, and evidence for an alternative splicing event affecting protein function. Mamm Genome 1998, 9:54-57.
25. Ahn MY, Bae SC, Maruyama M, Ito Y: Comparison of the human genomic structure of the Runt domain-encoding PEBP2/CBFa gene family. Gene 1996, 168:279-280.
26. Mundlos S, Otto F, Mundlos C, Mulliken JB, Aylsworth AS, Albright S, Lindhout D, Cole WG, Henn W, Knoll JHM et al.: Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 1997, 89:773-779. Human CBFA1 cDNA is isolated and the deletion, insertion, and missense mutations in the CBFA1 locus are identified in patients with CCD. In-frame expansion of a polyalanine stretch leads to brachydactyly and minor clinical CCD pathologies. It is demonstrated that heterozygous loss of Cbfa1 causes CCD.
27. Banerjee C, McCabe LR, Choi J, Hiebert SW, Stein JL, Stein GS, Lian JB: Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex. J Cell Biochem 1997, 66:1-8. Antisense oligonucleotides of Cbfa1 inhibit the production of alkaline phosphatase and osteocalcin, and decrease the formation of mineralized nodules - indicating that Cbfa1 is a specific transcription factor for osteoblast differentiation. Overexpression of all three runt-domain genes (Cbfa-1, -2, and -3) induces osteocalcin expression - supporting the importance of a runt-homology-domain protein in regulating the expression of a bone-specific gene.
28. Jarvis JL, Keats TE: Cleidocranial dysostosis, a review of 40 new cases. Am J Radiol 1974, 121:5-16.
29. Mundlos S, Mulliken JB, Abramson DL, Warman ML, Knoll JHM, Olsen BR: Genetic mapping of cleidocranial dysplasia and evidence of a microdeletion in one family. Hum Mol Genet 1995, 4:71-75.
30. Mundlos S, Huang LF, Selby P, Olsen BR: Cleidocranial dysplasia in mice. Ann NY Acad Sci 1996, 785:301-302.
31. Levanon D, Negreanu V, Bernstein Y, Bar-Am I, Avivi L, Groner Y: AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization. Genomics 1994, 23:425-432.
32. •].
33. Zhang Y, Bae S, Takahashi E, Ito Y: The cDNA cloning of the transcripts of human PEBP2αA/CBFA1 mapped to 6p12.3-p21.1, the locus for cleidocranial dysplasia. Oncogene 1997, 15:367-371.
34. Merriman HL, van Wijnen AJ, Hiebert S, Bidwell JP, Fey E, Lian J, Stein J, Stein GS: The tissue-specific nuclear matrix protein, NMP-2, is a member of the AML/CBF/PEBP2/Runt domain transcription factor family: interaction with the osteocalcin gene promoter. Biochemistry 1995, 34:13125-13132.
35. Geoffroy V, Ducy P, Karsenty G: A PEBP2α/AML-1-related factor increases osteocalcin promoter activity through its binding to an osteoblast-specific cis-acting element. J Biol Chem 1995, 270:30973-30979.
36. Banerjee C, Hiebert SW, Stein JL, Lian JB, Stein GS: An AML-1 consensus sequence binds an osteoblast-specific complex and transcriptionally activates the osteocalcin gene. Proc Natl Acad Sci USA 1996, 93:4968-4973.
37. Miyazaki Y, Setoguchi M, Yoshida S, Higuchi Y, Akizuki S, Yamamoto S: The mouse osteopontin gene. J Biol Chem 1990, 265:14432-14438.
38. Yang R, Gerstenfeld LC: Structural analysis and characterization of tissue and hormonal responsive expression of the avian bone sialoprotein (BSP) gene. J Cell Biochem 1996, 64:128-139.
39. Rossert J, Eberspaecher H, Crombrugghe BD: Separate cis-acting DNA elements of the mouse pro-α1(I) collagen promoter direct expression of reporter genes to different type I collagen-producing cells in transgenic mice. J Cell Biol 1995, 129:1421-1432.
40. Bedalov A, Salvatori R, Dodig M, Kronenberg MS, Kapural B, Bogdanovic Z, Kream BE, Woody CO, Clark SH, Mack K et al.: Regulation of col1a1 expression in type I collagen producing tissues: identification of a 49 base pair region which is required for transgene expression in bone of transgenic mice. J Bone Miner Res 1995, 10:1443-1451.
41. •], in which type I collagen and osteocalcin expression are increased by the transfection of Cbfa1 that starts its translation from exon 1. It is suggested that the former Cbfa1 cDNA might act as a dominant negative-type regulator or that it might indirectly regulate expression via interaction with other transcription factors.
42. Wotton D, Ghysdael J, Wang S, Speck NA, Owen MJ: Cooperative binding of ets-1 and core binding factor to DNA. Mol Cell Biol 1994, 14:840-850.
43. Wargnier A, Legros-Maida S, Bosselut R, Bourge JF, Lafaurie C, Ghysdael J, Sasportes M, Paul P: Identification of human granzyme B promoter regulatory elements interacting with activated T-cell-specific proteins: implication of Ikaros and CBF binding sites in promoter activation. Proc Natl Acad Sci USA 1995, 92:6930-6934.
44. Zhang D, Hetherington CJ, Meyers S, Rhoades KL, Larson CJ, Chen H, Hiebert SW, Tenen DG: CCAAT enhancer-binding protein (C/EBP) and AML1 (CBFα2) synergistically activate the macrophage colony-stimulating factor receptor promoter. Mol Cel Biol 1996, 16:1231-1240.
45. Zaiman AL, Lenz J: Transcriptional activation of a retrovirus enhancer by CBF (AML1) requires a second factor: evidence for cooperativity with c-Myb. J Virol 1996, 70: 5618-5629.
46. Chang DJ, Ji C, Kim KK, Casinghino S, McCarthy TL, Centrella M: Reduction in transforming growth factor β receptor I expression and transcription factor CBFa1 on bone cells by glucocorticoid. J Biol Chem 1998, 273:4892-4896. Glucocorticoid is found to suppress Cbfa1 and the TGF-β type I receptor. It is suggested that bone loss caused by glucocorticoid may be mediated in part by Cbfa1 via the TGF-β type I receptor as the promoter for TGF-β type I receptor contains a Cbfa1-binding site. This paper indicated the importance of Cbfa1 in glucocorticoid-dependent bone loss.
47. Schorpp M, Mattel M-G, Herr I, Gack S, Schaper J, Angel P: Structural organization and chromosomal localization of the mouse collagenase type I gene. Biochem J 1995, 308:211-217.
48. Pendás AM, Balbin M, Llano E, Jiménez MG, López-Otin C: Structural analysis and promoter characterization of the human collagenase-3 (MMP13). Genomics 1997, 40:222-233.
49. Tardif G, Pelletier J-P, Dupuis M, Hambor JE, Martel-Pelletier J: Cloning, sequencing and characterization of the 5′ -flanking region of the human collagenase-3 gene. Biochem J 1997, 323:13-16.
50. Kobayashi T, Sugimoto T, Saijoh K, Fujii M, Chihara K: Cloning and characterization of the 5′ -flanking region of the mouse diastrophic dysplasia sulphate transpoter gene. Biochem Biophys Res Commun 1997, 238:738-743.